|
Credentials |
|
Research Paroxetine v. Placebo in Obsessive Compulsive Disorder 1991-1993 Paroxetine v. fluoxetine v. Placebo in Depression 1991 Paroxetine v. alprazolam v. Placebo in Panic 1992-1994 Fixed Dose DN 2327 v. Placebo in Generalized Anxiety Disorder 1992-1994 Long term Treatment with DN 2327 in Anxiety 1993-1994 Nefazadone in the Treatment of Depression in General Psychiatric Practices, an open label trial 1993-1995 Outcomes Round Table, Johns Hopkins University 1996-1998 Open Label Trial of Aricept for Traumatic Brain Injury 1997 Quetiapine Experience with Safety and Tolerability 1997-1998 Paroxetine in PTSD 1999 Selegiline transdermal system for depression 1999-2001 The Combination of Olanzapine and Fluoxetine in Treatment Resistant Depression Without Psychotic Features 2000-2001 An Open-Label, Compassionate Use Study of the Selegiline Transdermal System in Patients with Major Depression 2000-2003 A Double Blind, placebo controlled, 3 arm fixed dose study of paroxetine CR continuous treatment for Premenstrual Dysphoric Disorder 2001-2002 A MultiCenter, Double-blind, Randomized Comparison of the Efficacy and Safety of Quetiapine Fumarate and Risperidone in the Treatment of patients with Schizophrenia 2001-2002 A 3-month, double-blind, placebo controlled, fixed dose, extension study of paroxetine CR continuous treatment for PMDD patients completing 29060/689 2001-2002 A Randomized, Double Blind, Placebo Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder 2001-2002 A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study Evaluating Efficacy and Safety of SB-659746-A versus Placebo in Patients with Major Depressive Disorder 2001-2002 Examining Clinical Experience with Escitalopram in Depression 2002 A 6-1/2 Month, Multicenter, Randomized, Double-Blind, Placebo Controlled Comparison of 300 mg/day of Wellbutrin XL and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder 2002-2003 A Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride and Escitalopram in Outpatients with Moderate to Severe Major Depression over an Eight-Week Treatment Period 2002-2003 A 7 Month, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of 150-300 mg/day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Affective Disorder in Subjects with a History of Seasonal Affective Disorder followed by an 8 week Observational Follow-up Phase 2003-2004 Lilly Emotional and Physical Symptoms of Depression Study 2003-2004 An Open Label Study of Tolerability, Clinical Response, and Satisfaction in Adult Bipolar I Subjects Optimizing Initiation of Therapy Using Administration of Dermatological Precautions and Lamictal Titration Packs, Phase IV Study 2003-2004 Optimizing Administration of Lamictal: SCA40917. An Open Label Study of Tolerability, Clinical Response, and Satisfaction in Adult and Adolescent Bipolar I Subjects Optimizing Initiation of Therapy Using Administration of Dermatological Precautions and Lamictal Titration Packs, Phase IV Study 2004-2005 A 52 Week Multi-centre, Double-blind, Randomized, Withdrawal, Parallel group, Placebo-controlled, Phase III Study of the Efficacy (Time to Event) and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR) 50, 150, 300 mg/day as Monotherapy in the Maintenance Treatment of Patients with Major Depressive Disorder Following a 16 Week, Open-Label Stabilisation Period 2005-2006 A Six –Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating the Efficacy of Flexible Doses of Oral Ziprasidone as Add-On, Adjunctive Therapy with Lithium, Valproate or Lamotrigine in Bipolar Depression 2007-present JOURNAL REVIEWER: Journal of Forensic Sciences 1989-present The American Journal of Drug and Alcohol Abuse 1991-present Hospital and Community Psychiatry 1991-1994 The Bulletin of the American Academy of Psychiatry and the Law 1991-present Associate Editor, American Academy of Psychiatry and the Law Newsletter 1991-present Psychiatric Times 1993-present Psychiatric Services 1994-present The American Journal on Addictions 1995-present Associate Editor, Delaware Medical Journal 2000-present The Journal of Neuropsychiatry and Clinical Neurosciences 2003-present The Journal of Clinical Psychiatry 2003-present Advisory Board, Advanced Studies in Medicine, 2006-present Journal of Psychopharmacology 2007-present The Open Law Journal, Editorial Board Member 2007-present
|